Customize this page|
0
Votes
vote
SEA technology to increase potency of monoclonal antibodiesSeattle Genetics, Inc. announced today the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of monoclonal antibodies through enhanced effector function. The technology will be presented today by Dennis Benjamin, Ph.D., Senior Director, Che... |
United Kingdom
You are in 
Choose your city Change
Choose your city Change
07
Nov
-
30°
46% now -
Today
23° / 31° -
Sun
20° / 27° -
Mon
21° / 28°
Feeds with all content in English
About Keegy
Blog
Help
Contact
Who
Webmasters
Suggest a feed
Statistics
Contents belongs to their owners with their original licenses.
- South America
-
Argentina
• Bolivia
• Brazil
• Chile
• Colombia
• Ecuador
• Paraguay
• Peru
• Uruguay
• Venezuela
- Central America
- Costa Rica • Cuba • El Salvador • Guatemala • Honduras • Nicaragua • Panama • Puerto Rico • Rep. Dominicana
- North America
- Canada • Mexico • United States • US en español
- Europe
-
Spain
• France
• Italy
• Portugal
• United Kingdom
- Other countries
- India • Australia